PDCD4 is a CSL associated protein with a transcription repressive function in cancer associated fibroblast activation

DSpace/Manakin Repository

PDCD4 is a CSL associated protein with a transcription repressive function in cancer associated fibroblast activation

Citable link to this page

 

 
Title: PDCD4 is a CSL associated protein with a transcription repressive function in cancer associated fibroblast activation
Author: Jo, Seung-Hee; Kim, Dong Eun; Clocchiatti, Andrea; Dotto, G. Paolo

Note: Order does not necessarily reflect citation order of authors.

Citation: Jo, Seung-Hee, Dong Eun Kim, Andrea Clocchiatti, and G. Paolo Dotto. 2016. “PDCD4 is a CSL associated protein with a transcription repressive function in cancer associated fibroblast activation.” Oncotarget 7 (37): 58717-58727. doi:10.18632/oncotarget.11227. http://dx.doi.org/10.18632/oncotarget.11227.
Full Text & Related Files:
Abstract: The Notch/CSL pathway plays an important role in skin homeostasis and carcinogenesis. CSL, the key effector of canonical Notch signaling endowed with an intrinsic transcription repressive function, suppresses stromal fibroblast senescence and Cancer Associated Fibroblast (CAF) activation through direct down-modulation of key effector genes. Interacting proteins that participate with CSL in this context are as yet to be identified. We report here that Programmed Cell Death 4 (PDCD4), a nuclear/cytoplasmic shuttling protein with multiple functions, associates with CSL and plays a similar role in suppressing dermal fibroblast senescence and CAF activation. Like CSL, PDCD4 is down-regulated in stromal fibroblasts of premalignant skin actinic keratosis (AKs) lesions and squamous cell carcinoma (SCC). While devoid of intrinsic DNA binding capability, PDCD4 is present at CSL binding sites of CAF marker genes as well as canonical Notch/CSL targets and suppresses expression of these genes in a fibroblast-specific manner. Thus, we propose that PDCD4 is part of the CSL repressive complex involved in negative control of stromal fibroblasts conversion into CAFs.
Published Version: doi:10.18632/oncotarget.11227
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312270/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:32072034
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters